CureVac N.V. (ETR:5CV)
2.718
-0.068 (-2.44%)
Mar 31, 2025, 2:35 PM CET
CureVac Employees
As of December 31, 2023, CureVac had 1,172 total employees, including 999 full-time and 173 part-time employees. The number of employees increased by 123 or 11.73% compared to the previous year.
Employees
1,172
Change (1Y)
123
Growth (1Y)
11.73%
Revenue / Employee
€60,644
Profits / Employee
€256,381
Market Cap
617.12M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1,172 | 123 | 11.73% |
Dec 31, 2022 | 1,049 | 165 | 18.67% |
Dec 31, 2021 | 884 | 330 | 59.57% |
Dec 31, 2020 | 554 | 100 | 22.03% |
Dec 31, 2019 | 454 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Merck KGaA | 59,020 |
Siemens Healthineers AG | 72,000 |
Fresenius SE & Co. KGaA | 193,865 |
Bayer Aktiengesellschaft | 90,587 |
Sartorius Aktiengesellschaft | 13,528 |
Fresenius Medical Care AG | 111,513 |
Carl Zeiss Meditec AG | 5,730 |
Fielmann Group AG | 23,412 |
CureVac News
- 2 days ago - CureVac: Patent Win Notable, But Won't Answer More Fundamental Questions - Seeking Alpha
- 2 days ago - CureVac Shares Rise on Patent Confirmation Amid BioNTech Lawsuit - Market Watch
- 3 days ago - European Patent Office Rules Vaccine Developer CureVac's Amended Patent Valid, Stock Jumps - Benzinga
- 3 days ago - European Patent Office Rules Vaccine Developer CureVac's Amended Patent Valid, Stock Jumps - Benzinga
- 3 days ago - European Patent Office declares CureVac mRNA patent valid - Reuters
- 3 days ago - CureVac up 13% as court upholds validity of patent in BioNTech spat - Seeking Alpha
- 3 days ago - CureVac Receives Positive Validity Decision from European Patent Office in Litigation Against BioNTech SE - Wallstreet:Online
- 3 days ago - CureVac Receives Positive Validity Decision from European Patent Office in Litigation Against BioNTech SE - Accesswire